Cancer of the uterine cervix is the most common cancer among women in developing countries . Four-fifths of the estimated 437 000 new cases in the world in 1985 occurred in developing countries. It is the most common cancer among women in India. The age-adjusted incidence rates of cervical cancer in India varied from 15 to 44 per 100 000 women in different regions in 1989 (ICMR, 1991) . Approximately one-sixth to one-fifth of all incident cervical cancers in the world occur in India, and it is estimated that 100 000 incident cervical cancer cases will occur by the year 2001. (ICMR, 1991) . Hence, control of cervical cancer is one of the major goals of the National Cancer Control Programme (NCCP) of India.
In this paper we address the hospital-based survival experience of 452 cervical cancer patients registered during 1984 at the Regional Cancer Centre, Trivandrum. The follow-up information for this study was obtained by scrutinising case records and by sending reply-paid postcards to those for whom only incomplete information was available in the case records. Two contact addresses in addition to the permanent address of the patient were routinely collected at the time of registration. These addresses are normally used to enquire about the health of patients if they do not turn up for follow-up (Varghese et al., 1991) . The patients themselves, the relatives/friends or the local postman usually respond to such enquiries by informing the registry of the status of the patient. At 5 years, 118 (26%) were alive, 173 (38%) were known to be dead, and 161 (36%) were lost to followup at varying periods of time (107 in the first year, 25 in the second year, 15 in the third and 14 in the fourth year).
The observed survival rates were calculated using the Kaplan-Meier product limit method (Kaplan and Meier, 1958) . Survival rates according to the categorical variables age, SES and others were also calculated. The log-rank test was used in a univariate analysis to identify potentially important prognostic variables. These were then entered stepwise into a proportional hazards regression model (Cox, 1972) . Under the assumption of proportionality, the parameters estimated in such models can be interpreted as hazard ratios for levels of the variables of interest.
Results
The overall estimated 5 year survival rate was 47.4% (95% CI, 41.6-52.9%) (Figure 1) (Figure 2 ) and those with poor performance status (Figure 3 ) and advanced stages of disease (Figure 4 ). The differences in survival rates between categories of these variables were statistically significant in the univariate analysis. The mortality ratios associated with these variables persisted in the multivariate analysis, suggesting strong independent effects (Table II) . The hazard ratios were statistically significant for advanced stages of disease, low socioeconomic group and poor performance status. The (Sankaranarayanan et al., 1992) . Hospital-based information suffers from selection bias; the results are not readily generalised and comparisons with other data may be misleading. However, the Regional Cancer Centre in Trivandrum is the only cancer treatment facility catering for the needs of the population in southern Kerala; thus, the selection bias involved may be small, and the results should reflect the pattern of disease in this population. With the awareness of the limitations of hospital-based data, we have compared the survival outcome in this series with data reported from elsewhere.
The observed 5 year survival of 47.4%, although similar to that reported from some developing regions of the world, is considerably lower than in developed countries. The observed 5 year survival rate was 54% for cervical cancer cases diagnosed during 1980-85 in Puerto Rico; the survival was 68% for localised cancers, and 37% for advanced stage (Martinez et al., 1989) . The observed 5 year survival rate was 43.6% for cases diagnosed during 1982-86 in Cuba; the rates were 53% for localised cancers and 21 % for advanced stages (M Boschmonar, personal communication). The 5 year survival rate was 57.0% for cervical cancers diagnosed during 1980-84 in Shanghai, China (Yong-bing et al., 1990) .
The 5 year survival rates reported from developed countries vary from 50% to 75%. The 5 year relative survival rates in countries belonging to the European Community were among 50-60% (Black et al., 1993; Esteve et al., 1993) . The SEER programme in the United States reported 65.9% 5 year survival for cervical cancers diagnosed during 1983-87; it was 89.2% for localised, 51.5% for regional, 13.5% for distant and 54.5% for unstaged cancers (Miller et al., 1992) . The 5 year survival was 68.1% for white females compared to 56.4% for black females. The survival difference is explained by the fact that half of the white patients had localised disease compared to a third of black patients. The South Australian Central Cancer Registry reported 73% 5 year survival for cervical cancers diagnosed during 1982 -87 (Bonett et al., 1991 . The Osaka population-based registry in Japan, reported a 5 year survival rate of 70.5% for cervical cancers diagnosed during 1981-83 (Osaka Prefectural Health Department, 1991) . A hospital registry-based study in the National Cancer Centre Hospital, Japan revealed a 5 year survival rate of 74.7% for cervical cancers registered in 1984 (Kakizoe, 1991) . The 5 year survival observed in western populations reflects the outcome due to a higher proportion of localised cervical cancers.
Socioeconomic status (SES), performance status and clinical extent of disease emerged as prognostic factors for cervical cancer in our study. SES has a bearing on general health, nutritional status, attitudes, beliefs and health behaviour. The effect of SES on survival is probably mediated by these factors. The performance status is influenced by general health status, nutrition and the clinical extent of disease. These factors thus influence treatment as well. Although the assessment of the performance status was crude, it did discriminate the outcome to an extent. The lower survival rates reported in developing countries reflect mostly the advanced stages of disease at presentation and probably, to an extent, inadequate treatment due to poor compliance of patients and inadequate facilities for therapy. In our series less than 20% had localised disease; one-fifth of the patients did not comply with treatment. The 5 year survival rates observed for stage IB in our series are lower than the usual 80-90% 5 year survival reported for this stage. This may be partly due to stage misclassification and treatment inadequacies.
The fact that there have only been marginal improvements in the survival of patients with stage III and IV cervical cancer over the last 7 decades in spite of technological advances in treatment, points to the necessity of diagnosing cancers in early stages and treating them appropriately (Ponten et al., 1995) . Clinical downstaging may improve survival rates, but a more effective and prudent approach would be to prevent invasive cervical cancer and thereby reduce mortality by implementing feasible and effective Pap smear screening profocols. In this context whether lowintensity cytology approaches, such as a single Pap smear or smears at longer intervals (e.g. once in 10 years) in women aged 35 years and above, could reduce mortality from cervical cancer remains to be evaluated. Data from India indicate that 90% of the cervical cancers occur among women 35 years or older (ICMR, 1991) . Initiating screening earlier will substantially increase costs with marginal additional benefits. Meanwhile, efforts should be made to improve the awareness of the general population which might prompt symptomatic women to present in earlier stages.
